Volume 25, Number 5—May 2019
Dispatch
Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018
Table 2
GenBank sequence of NiV |
Partial genome | Complete genome | |||||||
---|---|---|---|---|---|---|---|---|---|
Nucleotide divergence, % |
Amino acid divergence, % |
Nucleotide similarity, % |
Amino acid similarity, % |
Nucleotide divergence, % |
Amino acid divergence, % |
Nucleotide similarity, % |
Amino acid similarity, % |
||
MH523645_NV/IN/bat/2018/15/Kerala | 0.3 | 1.1 | 99.7 | 98.9 | NA | NA | NA | NA | |
MH523644_NV/IN/bat/2018/Kerala | 0.0 | 0.0 | 100.0 | 100.0 | NA | NA | NA | NA | |
MH523643_NV/IN/bat/2018/Kerala | 0.6 | 1.1 | 99.4 | 98.9 | NA | NA | NA | NA | |
MH523641_NV/IN/HU/2018/Kerala | 0.0 | 0.0 | 100.0 | 100.0 | 0.0 | 0.0 | 100.0 | 100.0 | |
MH523640_NV/IN/HU/2018/Kerala | 0.0 | 0.0 | 100.0 | 100.0 | 0.0 | 0.0 | 100.0 | 100.0 | |
MH423323_NV/IN/HU/2018/Kerala/H1087_urine | 0.0 | 0.0 | 100.0 | 100.0 | 0.0 | 0.0 | 100.0 | 100.0 | |
MH396625_NV/IN/HU/2018/Kerala_CS | 0.0 | 0.0 | 100.0 | 100.0 | NA | NA | NA | NA | |
KT163256.1_NV/isolate_33654/2011/Thailand | 2.8 | 5.3 | 97.2 | 94.7 | NA | NA | NA | NA | |
KT163247.1_NV/isolate_1753/2010/Thailand | 9.2 | 21.3 | 90.8 | 78.7 | NA | NA | NA | NA | |
KM034755.1_NiV_KD_C313_KH13/2013/Cambodia | 8.9 | 21.3 | 91.1 | 78.7 | NA | NA | NA | NA | |
JN808864.1_NV/BD/HU/2010/Faridpur | 1.9 | 3.2 | 98.1 | 96.8 | 2.1 | 4.8 | 97.9 | 95.2 | |
JN808863.1_NV/BD/HU/2008/RAJBARI | 2.8 | 6.4 | 97.2 | 93.6 | 2.2 | 4.8 | 97.8 | 95.2 | |
JN808857.1_NV/BD/HU/2008/MA | 2.8 | 6.4 | 97.2 | 93.6 | 2.2 | 4.8 | 97.8 | 95.2 | |
FN869553.1_NV/MY/PV/2008/perak | 9.8 | 22.3 | 90.2 | 77.7 | 7.1 | 14.9 | 92.9 | 85.1 | |
FJ513078.1_NV/IN/HU/2007/FG | 2.5 | 5.3 | 97.5 | 94.7 | 2.2 | 4.8 | 97.8 | 95.2 | |
AY988601.1_NV/BD/HU/2004/RA1 | 2.2 | 4.3 | 97.8 | 95.7 | 2.1 | 4.7 | 97.9 | 95.3 | |
AY858110.1_NV/KHM/CSUR381/Cambodia | 10.1 | 22.3 | 89.9 | 77.7 | NA | NA | NA | NA | |
AY029768.1_NV/MY/HU/1999/UM2 | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 | |
AY029767.1_NV/MY/HU/1999/UM1 | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 | |
AJ627196.1_NV/MY/PI/1999/VRI-0626 | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 | |
AJ564623.1_NV/MY/HU/1999/UM-0128 | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 | |
AJ564622.1_NV/MY/PI/1999/VRI-1413 | 10.1 | 22.3 | 89.9 | 77.7 | 8.5 | 17.1 | 91.5 | 82.9 | |
AJ564621.1_NV/MY/PI/1999/VRI-2794 | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 | |
AF212302.2_NV/MY/HU/1999/CDC | 10.1 | 22.3 | 89.9 | 77.7 | 8.6 | 17.1 | 91.4 | 82.9 |
*NA, not applicable.
Page created: April 18, 2019
Page updated: April 18, 2019
Page reviewed: April 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.